Post by beMedTech

💓 Cardiovascular disease remains the leading cause of death in Europe, claiming 1.7 million lives each year. In Belgium, more than 30,000 people die annually from cardiovascular conditions. But what if we could act 𝘣𝘦𝘧𝘰𝘳𝘦 symptoms appear? That’s exactly the ambition behind the European Cardiovascular Health Plan currently in development, an initiative that Prof. Damien GRUSON strongly supports. As a leading expert in laboratory medicine and active member of several national and international bodies, he shares how diagnostics are essential to making prevention a reality. Two concrete examples from cardiovascular care: 👉 A one-time test for LP(a) to better define cardiovascular risk 👉 (NT-)proBNP testing to help detect heart failure before symptoms arise. These tests are not expenses, they are 𝘀𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗰 𝗶𝗻𝘃𝗲𝘀𝘁𝗺𝗲𝗻𝘁𝘀 in timely action, better outcomes and more efficient healthcare systems. Yet implementation remains a challenge. To make the value of diagnostics truly visible, we must combine diagnostic data with clinical and economic evidence. Only then can we gain a more complete picture of their impact. 𝗔𝗻𝗱 𝘀𝗵𝗶𝗳𝘁 𝘁𝗵𝗲 𝗰𝗼𝗻𝘃𝗲𝗿𝘀𝗮𝘁𝗶𝗼𝗻 𝗳𝗿𝗼𝗺 𝘁𝗵𝗲 𝗰𝗼𝘀𝘁 𝗼𝗳 𝘁𝗲𝘀𝘁𝗶𝗻𝗴 𝘁𝗼 𝘁𝗵𝗲𝗶𝗿 𝘃𝗮𝗹𝘂𝗲 𝗶𝗻 𝗱𝗲𝗹𝗶𝘃𝗲𝗿𝗶𝗻𝗴 𝗲𝗳𝗳𝗲𝗰𝘁𝗶𝘃𝗲, 𝘁𝗮𝗿𝗴𝗲𝘁𝗲𝗱 𝗰𝗮𝗿𝗲. ---------------------------------------------------- 🌐 Read the full interview with Prof. GRUSON on our website: • in Dutch: https://lnkd.in/emTUCBGD • in French: https://lnkd.in/eAsdfhen ---------------------------------------------------- #Diagnostics #MedTechMatters #IVD #Prevention #LaboratoryMedicine #CardiovascularHealth #ChronicDiseases